Management of Diabetic Nephropathy in the Elderly: Special Considerations.

作者: Emaad M Abdel-Rahman , Tarek Alhamad , W Brian Reeves , Alaa S Awad

DOI: 10.4172/2161-0959.1000124

关键词: MedicineProteinuriaInternal medicineGlycemicDiabetes mellitusAngiotensin-converting enzymeAlbuminuriaDiabetic nephropathyDiseasePopulationBioinformatics

摘要: The incidence and prevalence of End-Stage Renal Disease (ESRD) secondary to Diabetic Nephropathy (DN) have been progressively increasing, reaching pandemic proportions over the past 20 years. Diabetes mellitus is responsible for more than 40% all cases ESRD in United States. Despite that, treatment DN still suboptimal. Both elderly diabetic populations are among fastest growing categories. While several guidelines available management general population, patients unique characteristics that may require adaptation therapeutic used population. Current therapy directed at delaying progression includes optimal glycemic blood pressure control, proteinuria/albuminuria reduction, interruption renin-angiotensin-aldosterone system through use angiotensin converting enzyme inhibitors type-1 receptor blockers, along with dietary modification cholesterol lowering agents. This review highlights standard approaches manage progressive elderly.

参考文章(117)
Jerry Avorn, Rhonda L. Bohn, Elliott Levy, Raisa Levin, William F. Owen, Wolfgang C. Winkelmayer, Robert J. Glynn, Nephrologist Care and Mortality in Patients With Chronic Renal Insufficiency JAMA Internal Medicine. ,vol. 162, pp. 2002- 2006 ,(2002) , 10.1001/ARCHINTE.162.17.2002
George L. Bakris, J. Brian Copley, Nancy Vicknair, Rebecca Sadler, Sue Leurgans, Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy Kidney International. ,vol. 50, pp. 1641- 1650 ,(1996) , 10.1038/KI.1996.480
P. Koskinen, M. Manttari, V. Manninen, J. K. Huttunen, O. P. Heinonen, M. H. Frick, Coronary heart disease incidence in NIDDM patients in the Helsinki heart study Diabetes Care. ,vol. 15, pp. 820- 825 ,(1992) , 10.2337/DIACARE.15.7.820
Adem Ozkara, Faruk Turgut, Yusuf Selcoki, Aydin Karanfil, Melike Rusen Metin, Mehmet Kanbay, Oguz Tekin, Ali Akcay, None, Probrain natriuretic peptide for assessment of efficacy in heart failure treatment. Advances in Therapy. ,vol. 24, pp. 1233- 1239 ,(2007) , 10.1007/BF02877769
George L. Bakris, Matthew R. Weir, Michelle Secic, Brett Campbell, Annette Weis-McNulty, Differential effects of calcium antagonist subclasses on markers of nephropathy progression Kidney International. ,vol. 65, pp. 1991- 2002 ,(2004) , 10.1111/J.1523-1755.2004.00620.X
Steen Andersen, Lise Tarnow, Peter Rossing, Birgitte V. Hansen, Hans-Henrik Parving, Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy Kidney International. ,vol. 57, pp. 601- 606 ,(2000) , 10.1046/J.1523-1755.2000.00880.X
A. K. Ahmed, N. S. Kamath, M. El Kossi, A. M. El Nahas, The impact of stopping inhibitors of the renin–angiotensin system in patients with advanced chronic kidney disease Nephrology Dialysis Transplantation. ,vol. 25, pp. 3977- 3982 ,(2010) , 10.1093/NDT/GFP511
Hajime Orimo, Hideki Ito, Takao Suzuki, Atsushi Araki, Takayuki Hosoi, Motoji Sawabe, Reviewing the definition of “elderly” Geriatrics & Gerontology International. ,vol. 6, pp. 149- 158 ,(2006) , 10.1111/J.1447-0594.2006.00341.X
P. M. Nilsson, J. Cederholm, Diabetes, Hypertension, and Outcome Studies: Overview 2010 Diabetes Care. ,vol. 34, pp. S109- S113 ,(2011) , 10.2337/DC11-S204
Johannes FE Mann, Roland E Schmieder, Matthew McQueen, Leanne Dyal, Helmut Schumacher, Janice Pogue, Xingyu Wang, Aldo Maggioni, Andrzej Budaj, Suphachai Chaithiraphan, Kenneth Dickstein, Matyas Keltai, Kaj Metsärinne, Ali Oto, Alexander Parkhomenko, Leopoldo S Piegas, Tage L Svendsen, Koon K Teo, Salim Yusuf, None, Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial The Lancet. ,vol. 372, pp. 547- 553 ,(2008) , 10.1016/S0140-6736(08)61236-2